Autolus Therapeutics
NasdaqGS:AUTL
$ 1,33
+ $0,01 (0,76%)
1,33 $
+$0,01 (0,76%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,86
Earnings Per Share
$0,04
Revenue Per Share
0,00%
Gross Margin %
$0,35 B
Market Cap
$0,25 B
Long-Term Debt
Earnings Per Share
$-0,86
Revenue Per Share
$0,04
Gross Margin %
0,00%
Market Cap
$0,35 B
Long-Term Debt
$0,25 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $-0,86 $-0,86 $-1,20 $-1,57 $-1,97 $-2,76 $-2,79 $-1,11
Earnings Earnings $-228,87M $-228,87M $-319,12M $-271,72M $-179,09M $-144,49M $-125,49M $-44,57M
RPS Revenue Per Share $0,04 $0,04 $0,01 $0,04 $0,03 $0,03 $0,06 $0,04
Revenue Revenue $10,12M $10,12M $1,70M $6,36M $2,33M $1,72M $2,91M $1,41M
OCF Operating Cash Flow $-206,27M $-206,27M $-145,59M $-112,31M $-117,86M $-117,76M $-101,48M $-31,54M
FCF Free Cash Flow $-230,29M $-228,35M $-183,17M $-123,15M $-126,72M $-132,44M $-119,83M $-40,66M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-0,94 $-0,90 $-1,30 $-1,76 $-2,57 $-2,79 $-1,63
LT Debt Long-Term Debt $244,60M $244,60M $170,90M $125,90M $47,02M N/A N/A N/A
Sha. Stocks 266,13M 266,13M 265,93M 173,07M 90,91M 52,35M 44,98M 40,15M
×